Indian Pharmaceutical Companies To Use experimental Drugs To 49 Infant Deaths
India 49 babies in India to participate in a major hospital drug pilot scheme, the tragic death. Many big pharmaceutical companies around the world are in India for a variety of new drugs in clinical trials, this incident has given rise to concern, criticized the use of baby test pharmaceutical drugs, have requested the authorities to take action to improve ethical standards in this regard.
These babies have been in the 30 months to die, location is located in Delhi’s All India Institute of Medical Sciences. The center is well-known in India, many as an elite of medical students are trained at the center, but also a lot of the poor and the general public to provide cheap medical services, have always enjoyed a good reputation.
Since since January 2006, a total of 4142 infants in the 42 hospitals to participate in clinical trials, mainly as a new drug for the final stage of testing. In these babies, of which 2728 were less than one year old. Many of these babies to participate in pre-clinical trials have been seriously ill, they test the mortality rate was 1.2 percent ─ ─ significantly lower than that of the hospital for treatment of patients of all mortality, the latter four.
However, the choice of testing the child’s age of low, shocked many Indians, it is feared that more and more profitable pharmaceutical industry might use unethical people to take the short cut. India Union Government’s main political parties Congress Party spokesman said: “This kind of the baby as guinea pigs to test drugs practices must be stopped.”
Rights groups worry that those who visit, like the All India Institute of Medical Sciences which public subsidy for the agency to provide parents, as are poor and often illiterate, so they may not know that test new drugs so that the baby contains consequences.
90 percent are poor drug test
In the medical profession, the general principles of human trials is that patients fully understand the purpose of testing and possible risks to agree to participate in the trial after. At this point, patients in Western countries are quite cautious. In the United States, only 3 percent of cancer patients willing to participate in clinical trials of new drugs. India 90% of the test drug were poor, most of them no culture, it is difficult to understand the risks.
India has become an international pharmaceutical companies outsourcing clinical trials of the major countries, and this is mainly due to India’s population and diverse gene pool complex, as well as low-cost do such tests. It is predicted that by 2010, India’s human clinical trials will be the proceeds of one billion pounds in the industry.
India’s tests adequate object. India has more than one billion population, from the ethnic point of view, India has a white, yellow and black, is ideal for a large gene pool for drug testing.
India is also the type of illness in patients with Europe and the United States and other countries are very similar, only there are 32 million people with diabetes. Many people because of poverty have not eaten any medication to treat their disease, which would avoid the drug with the old drugs between the mutual interference. More importantly, clinical trials in India, the cost is much lower. According to the Dutch Agricultural Cooperative Bank estimates, clinical trials in India can be R & D costs六成.
A shortage of 30,000 researchers
However, the Government of India Planning Commission, recent studies have shown that the country’s chronic lack of trained researchers. The report found that researchers in the country a shortfall of 3-50000, including the trial investigators, auditors, the incumbent ethics committee and data safety management committee of qualified staff.
Control of the country’s weak infrastructure, responsible for approving the drug test drug control bureau of inadequate staffing.
All India Institute of Medical Sciences is a great reputation in the international institutions, the hospital spokesman said that there is a very important fact that must be pointed out that that is not yet known at present how many of the deceased is the use of infant drug test, and how many are the control group infants.
It is understood that the Indian Health forces Rama Doss, has ordered investigation into the deaths, the investigation will focus on the All India Institute of Medical Sciences 2 by the World Health Organization and the Indian government-funded trial. Test the time being is not clear what therapy.
job in pharma. production